Apply to trial NCT07625293

A few quick questions so the study team can decide if you might be a fit.

RecruitingPhase 2Biological intervention

DB-3Q for the Treatment of Medically Refractory Crohn's Disease

This research study is studying DB-3Q as a possible treatment for medically refractory Crohn's disease. The purpose of this study is to research and evaluate safety and effectiveness of the administration of bone marrow mesenchymal stem cell (bmMSC) derived extracellular vesicles product, DB-3Q, the study drug for Crohn's disease.

How this works

Answer a few questions
About 5 to 10 minutes. Skip-friendly where possible.
We connect you with the study team
When a site picks up your application, we introduce you to their team directly — with you on the thread.
The team reaches out to schedule screening
Usually within a few business days, via the contact you give.

EmailWe save your progress under this email and copy you when we connect you with the study team.

I agree that Hipa.ai may share my application — my name, contact details, and my answers, including health information — with the official study team for this trial so they can review my responses and contact me.

By continuing, you agree to our terms of service.

DB-3Q for the Treatment of Medically Refractory Crohn's Disease

How this works

Answer a few questions

We connect you with the study team

The team reaches out to schedule screening